Back to SYRE

GEODE CAPITAL MANAGEMENT, LLC → SYRE

GEODE CAPITAL MANAGEMENT, LLC SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
10
Latest value
$27.1M
Q3 2026
Peak value
$214.3M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$18M
Q3 2025$2.6M
Q4 2025$47.1M
Q4 2025$7.3M
Q1 2026$74.7M
Q1 2026$12.1M
Q2 2026$214.3M
Q2 2026$25M
Q3 2026$209.4M
Q3 2026$27.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$27.1M303.8K——
Q3 2026$209.4M2.25M——
Q2 2026$25M281.5K——
Q2 2026$214.3M2.28M——
Q1 2026$12.1M240.5K——
Q1 2026$74.7M1.48M——
Q4 2025$7.3M222.9K——
Q4 2025$47.1M1.44M——
Q3 2025$2.6M153.5K——
Q3 2025$18M1.07M——

Other funds holding SYRE

Other GEODE CAPITAL MANAGEMENT, LLC positions

NVDA

NVIDIA CORP

$122B
AAPL

APPLE INC

$108.8B
NVDA

NVIDIA CORP

$105.6B
NVDA

NVIDIA CORP

$96.7B
NVDA

NVIDIA CORP

$96.6B
AAPL

APPLE INC

$93.5B
NVDA

NVIDIA CORP

$91.6B
MSFT

MICROSOFT CORP

$86B